pharma · Moderate to severe systemic lupus erythematosus · Lupus Erythematosus, Systemic
Viatris Pharmaceuticals Co
Viatris Pharmaceuticals Co.,
News and analysis for Viatris Pharmaceuticals Co on NovaPharmaNews — regulatory, clinical, and market coverage.
FR HQ
4 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- FR
- Employees
- 4
- Programs
- 8
- Drugs
- 23
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Viatris Pharmaceuticals Co — regulatory, clinical, and market coverage.
News and analysis for Viatris Pharmaceuticals Co on NovaPharmaNews — regulatory, clinical, and market coverage.